At Getz Pharma, we are committed to enhancing patient access to critical medications, embodying a mission that is deeply ingrained in both our historical legacy and our forward-looking strategies. Positioned as a leading force in the pharmaceutical industry, our goal is to become the world’s foremost provider of high-quality generics and biosimilars. Annually, we facilitate over 800 million patient treatments globally.

Unique in our capability, Getz Pharma operates at scale in both the biosimilars and generics markets across more than 100 countries. This extensive reach and profound expertise empower us to make a significant impact on global health.

Our generics portfolio is categorized into standard generics, which primarily include oral solids, and complex generics that encompass injectables, respiratory therapies, and other advanced formulations.

Our offerings are designed to generate substantial savings for both patients and healthcare systems, contributing to the sustainability of healthcare infrastructure amid escalating economic challenges. We are dedicated to improving access and ensuring the availability of cost-effective healthcare solutions worldwide.